“poseida-therapeutics” Archives

in
Entry Author Date Location
Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold 08/18/20 San Diego
GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod 08/06/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info 05/13/20 New York
San Diego Roundup: Qualcomm, Philter, Stella Labs, VC Funding & More 07/19/19 San Diego
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round 04/22/19 San Diego
Government Shutdown Hits Biotech as FDA Punts Review of Aimmune Drug 01/15/19 San Francisco
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More 01/11/19 National
BCMA Day: At ASH ‘18, Cell Therapies For Myeloma Take Center Stage 12/04/18 National
With a New Name, Afyx Aims to Improve Oral Disease Treatment 09/27/18 San Diego
AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down 04/06/17 National
Page 1 of 1